SCHEMBL3351728

SCHEMBL3351728

COc1nc(N)c2cc(OCCCN3CCOCC3)ccc2n1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.51
HRH3 Q9Y5N1 3/20 0.51
MAPK1 P28482 2/20 0.51
SIGMAR1 Q99720 2/20 0.51
CYP1A2 P05177 1/20 0.51
CHRM2 P08172 1/20 0.51
CHRM1 P11229 1/20 0.51
HTR2A P28223 1/20 0.51
SCN1A P35498 1/20 0.51
HTR2B P41595 1/20 0.51
KCNH2 Q12809 1/20 0.51
SCN2A Q99250 1/20 0.51
SCN3A Q9NY46 1/20 0.51
TSHR P16473 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
USP2 O75604 1/20 0.50
LMNA P02545 1/20 0.50
AVPR1B P47901 4/20 0.49
FGFR1 P11362 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31061228 1.00 ALDH1A1 (0.51) ALDH1A1HRH3MAPK1SIGMAR1CYP1A2
SCHEMBL2502393 0.81 ALDH1A1 (0.54) ALDH1A1HRH3MAPK1SIGMAR1CYP1A2
SCHEMBL27076566 0.81 HRH3 (0.54) HRH3KCNH2
SCHEMBL239668 0.81 SIGMAR1 (0.56) ALDH1A1HRH3MAPK1SIGMAR1CYP1A2
SCHEMBL16245396 0.79 HRH3 (0.54) ALDH1A1HRH3MAPK1SIGMAR1CYP1A2
SCHEMBL3399864 0.78 KDM4E (0.53) ALDH1A1MAPK1KCNH2TSHRNPSR1
SCHEMBL12474212 0.77 EGFR (0.64) HRH3KCNH2SRC
SCHEMBL28959188 0.76 RAF1 (0.48) MAPK1AVPR1BSRC
SCHEMBL30017088 0.75 RAF1 (0.51) MAPK1AVPR1BSRC
SCHEMBL28959219 0.75 RAF1 (0.51) MAPK1AVPR1BSRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009090661-A9 6.7-DIALKOXY OUINAZOLINE DERIVATIVES USEFUL FOR TREATMENT OF CANCER RELATED DISORDERS NATCO PHARMA LIMITED (IN) 2010-06-17 WO disclosed